Drug intelligence / Profile preview

JunB shRNA

Development stage
Preclinical
Lead developer
National Center for Tumor Diseases Heidelberg
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

JunB shRNA is a gene-silencing therapeutic candidate primarily utilized in preclinical research to investigate the role of the AP-1 transcription factor JunB in multiple myeloma (MM). Delivered via viral vectors such as pLKO.1 or inducible Tet-systems, this short hairpin RNA (shRNA) specifically targets and reduces the expression of JunB. In the bone marrow microenvironment, JunB is induced by soluble factors like IL-6 and promotes MM cell proliferation, survival, and resistance to standard therapies like dexamethasone and bortezomib. By knocking down JunB, the expression of downstream pro-survival targets such as Mcl-1 and c-Myc is downregulated, leading to inhibited tumor growth and sensitized cancer cells to chemotherapy.

Other names
JunB short hairpin RNA
02

Targets

JUNB (Transcription factor JunB mRNA)

Beyond the preview

Go deeper on JunB shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on JunB shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call